Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy

被引:59
|
作者
Wang, Chenwei [1 ,2 ]
He, Wei [1 ,2 ]
Yuan, Yichuan [1 ,2 ]
Zhang, Yuanping [1 ,2 ]
Li, Kai [1 ,2 ]
Zou, Ruhai [1 ,3 ]
Liao, Yadi [1 ,2 ]
Liu, Wenwu [1 ,2 ]
Yang, Zhiwen [1 ,2 ]
Zuo, Dinglan [1 ]
Qiu, Jiliang [1 ,2 ]
Zheng, Yun [1 ,2 ]
Li, Binkui [1 ,2 ]
Yuan, Yunfei [1 ,2 ]
机构
[1] Sun Yat Sen Univ, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Hepatobiliary Oncol, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Dept Ultrasound, Canc Ctr, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
early recurrent hepatocellular carcinoma; inflammation-based prognostic score; prognosis predictor; systemic immune-inflammation index; INDEX PREDICTS; CANCER; RESECTION; IMPACT; RATIO;
D O I
10.1111/liv.14281
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims Inflammation-based prognostic scores, such as the Glasgow Prognostic Score (GPS), modified Glasgow Prognostic Score (mGPS), Prognostic Index (PI), Prognostic Nutritional Index (PNI), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), lymphocyte to monocyte ratio (LMR) and systemic immune-inflammation index (SII), are correlated with the survival of hepatocellular carcinoma (HCC) patients, while remain unclear for recurrent HCC. This study aimed to compare the prognostic value of inflammation-based prognostic scores for post-recurrence survival (PRS) in patients with early recurrent HCC (ErHCC, within 2 years after hepatectomy). Methods A total of 580 patients with ErHCC were enrolled retrospectively. The association between the independent baseline and the time-dependent variables and PRS was evaluated by cox regression. The prediction accuracy of the inflammation-based prognostic scores was assessed by time-dependent receiver operating characteristic (ROC) and Harrell's concordance index (C-index) analyses. Results The GPS, mGPS, PI, PNI, NLR, PLR, LMR and SII were all related to the PRS of ErHCC patients, while only the SII (P < .001) remained an independent predictor for PRS in multivariate analysis (hazard ratio: 1.92, 95% confidence interval: 1.33-2.79). Both the C-index of the SII (0.65) and the areas under the ROC curves showed that the SII score was superior to the other inflammation-based prognostic scores for predicting the PRS of ErHCC patients. Conclusions The SII is a useful prognostic indicator for PRS in patients with ErHCC after hepatectomy and is superior to the other inflammation-based prognostic scores in terms of prognostic ability.
引用
收藏
页码:229 / 239
页数:11
相关论文
共 50 条
  • [41] Novel inflammation-based prognostic nomograms for individualized prediction in hepatocellular carcinoma after radical resection
    Zeng, Jianxing
    Zeng, Jinhua
    Wu, Qionglan
    Lin, Kongying
    Zeng, Jianyang
    Guo, Pengfei
    Zhou, Weiping
    Liu, Jingfeng
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (17)
  • [42] An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma
    Pinato, David J.
    Sharma, Rohini
    TRANSLATIONAL RESEARCH, 2012, 160 (02) : 146 - 152
  • [43] Evaluation of Two Inflammation-Based Prognostic Scores in Patients with Resectable Gallbladder Carcinoma
    Xiang-Song Wu
    Liu-Bin Shi
    Mao-Lan Li
    Qian Ding
    Hao Weng
    Wen-Guang Wu
    Yang Cao
    Run-Fa Bao
    Yi-Jun Shu
    Qi-Chen Ding
    Jia-Sheng Mu
    Jun Gu
    Ping Dong
    Ying-Bin Liu
    Annals of Surgical Oncology, 2014, 21 : 449 - 457
  • [44] Usefulness of Inflammation-Based Prognostic Scores for Predicting the Risk of Complications After Radical Resection of Colorectal Carcinoma
    Man, Wenhao
    Lin, Huajun
    Liu, Zhao
    Jin, Lei
    Wang, Jin
    Zhang, Jun
    Bai, Zhigang
    Yao, Hongwei
    Zhang, Zhongtao
    Deng, Wei
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 1029 - 1038
  • [45] Evaluation of Two Inflammation-Based Prognostic Scores in Patients with Resectable Gallbladder Carcinoma
    Wu, Xiang-Song
    Shi, Liu-Bin
    Li, Mao-Lan
    Ding, Qian
    Weng, Hao
    Wu, Wen-Guang
    Cao, Yang
    Bao, Run-Fa
    Shu, Yi-Jun
    Ding, Qi-Chen
    Mu, Jia-Sheng
    Gu, Jun
    Dong, Ping
    Liu, Ying-Bin
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) : 449 - 457
  • [46] Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal Cancer
    Jomrich, G.
    Paireder, M.
    Gleiss, A.
    Kristo, I.
    Harpain, L.
    Schoppmann, S. F.
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2017, 2017
  • [47] Prognostic value of preoperative inflammation-based predictors in patients with bladder carcinoma after radical cystectomy
    Gui, Huiming
    Song, Yutong
    Yin, Yongsheng
    Wang, Hanzhang
    Rodriguez, Ronald
    Wang, Zhiping
    OPEN MEDICINE, 2021, 16 (01): : 816 - 825
  • [48] Prognostic Impact of Inflammation-Based Scores for Extrahepatic Cholangiocarcinoma
    Asakura, Riki
    Yanagimoto, Hiroaki
    Ajiki, Tetsuo
    Tsugawa, Daisuke
    Mizumoto, Takuya
    So, Shinichi
    Urade, Takeshi
    Nanno, Yoshihide
    Fukushima, Kenji
    Gon, Hidetoshi
    Komatsu, Shohei
    Kuramitsu, Kaori
    Goto, Tadahiro
    Asari, Sadaki
    Kido, Masahiro
    Toyama, Hirochika
    Fukumoto, Takumi
    DIGESTIVE SURGERY, 2022, 39 (2-3) : 65 - 74
  • [49] Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization
    Liu, Ying
    Shi, Menting
    Chen, Shuanggang
    Wan, Weiqi
    Shen, Lujun
    Shen, Binyan
    Qi, Han
    Cao, Fei
    Wu, Ying
    Huang, Tao
    Chen, Guanjian
    Mo, Jinqing
    Ye, Dongdong
    Zhang, Yinqi
    Feng, Ziqing
    Fan, Weijun
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (03) : 740 - 748
  • [50] A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study
    Proctor, Michael J.
    Morrison, David S.
    Talwar, Dinesh
    Balmer, Steven M.
    Fletcher, Colin D.
    O'Reilly, Denis St. J.
    Foulis, Alan K.
    Horgan, Paul G.
    McMillan, Donald C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (17) : 2633 - 2641